Table 2.
Mucinous carcinoma samples overview.
| Sample | Status | Metastasis | Treatment | Stage | Grade | Diagnosis | Specific immunostaining |
|---|---|---|---|---|---|---|---|
| 1 | alive without disease | none | carboplatin/paclitaxel | IC | BOT | Endometrioid adenocarcinoma with focal mucinous differentiation | mCEA+/− (extracellular), ER+, PAX8+ |
| 2 | dead, unknown reason | NA | carboplatin/paclitaxel | NA | 1 | Mucinous adenocarcinoma | CK7+, CK20+/−, PAX8+ |
| 3 | alive without disease | none | none | IA | BOT | Mucinous cystadenoma | mCEA+, CK7+, CK20+, PAX8+ |
| 4 | dead of disease | recurrence | oxaliplatin and Xeloda, 5FU | IIIB | 1 | Mucinous adenocarcinoma | CK7+, CK20−, PAX8+ |
| 5 | dead of disease | pelvic tumor | carboplatin/paclitaxel | IIIC | NA | Mucinous adenocarcinoma of uncertain origin in the ovary | mCEA+, CK7 focally+, CK20 focally+, PAX8− |
| 6 | dead of disease | pelvic tumor | carboplatin/paclitaxel | IIIC | NA | Mucinous adenocarcinoma of uncertain origin in the ovary | PAX8− |
| 7 | dead of disease | recurrence | palliative | NA | NA | Low-grade mucinous carcinoma | Archival slides unavailable for reassessment |
| 8 | dead of disease | pelvic tumor, liver | none | IA | BOT | Mucinous carcinomas | CK7+, CK20−, PAX8+ |
| 9 | dead of other reason | none | none | IC | 2 | Mucinous adenocarcinoma with neuroendocrine differentiation | mCEA+/−, CK7+, CK20−, PAX8+, Synaptophysin+/−, Chromogranin A+/− |
| 10 | dead of disease, after recurrence | residual tumor | none | IIIC | 2 | Mucinous adenocarcinoma of uncertain origin in the ovary | mCEA+, CK7+, CK20+, CDX2+/−, PAX8− |
| 11 | alive without disease | none | none | IA | 1 | Mucinous adenocarcinoma | mCEA+, CK7+, CK20+/−, PAX8−, CDX2−, ER−, PR− |
| 12 | alive without desease | none | none | IIC | 1 | Mucinous adenocarcinoma | mCEA+/−, CK7+, CK20+/−, PAX8+, CDX2+/−, CA 125− |
| 13 | Alive without disease | rectum | Adjuvant Oxaliplatin and Xeloda | IIB | NA | Mucinous adenocarcinoma | CEA+, CK7+, CK20+, CDX2+/− |
| 14 | Alive without disease | none | none | IA | 1 | Mucinous adenocarcinoma | CEA+, CK7+, CK20−, CDX2− |
| 15 | Alive without disease | none | none | IA | NA | Mucinous adenocarcinoma | Archival slides unavailable for reassessment |
| 16 | Alive with disease | pelvic tumor | HIPEC with MitomycinC | IVb | 2 with neuroendocrine differentiation | Mucinous adenocarcinoma | CEA+, CK7+, CK20+, CDX2+, Vilin |
| 17 | Dead of disease | pelvic tumor | none | IA | 1 | Mucinous adenocarcinoma | Archival slides unavailable for reassessment |
| 18 | Alive without disease | pelvic tumor | none | IA | 1 | Mucinous adenocarcinoma | Archival slides unavailable for reassessment |
| 19 | Alive without disease | pelvic tumor | none | IC | 1 | Mucinous adenocarcinoma | CK7+, CK20+, CDX2+, PAX8+ |